Diagnostic accuracy of artificial intelligence-enabled vectorcardiography versus myocardial perfusion SPECT in patients with suspected or known coronary heart disease

Abstract

Aim The present study evaluated with myocardial perfusion SPECT (MPS) the diagnostic accuracy of an artificial intelligence-enabled vectorcardiography system (Cardisiography, CSG) for detection of perfusion abnormalities.

Methods We studied 241 patients, 155 with suspected CAD and 86 with known CAD who were referred for MPS. The CSG was performed after the MPS acquisition. The CSG results (1) p-factor (perfusion, 0: normal, 1: mildly, 2: moderately, 3: highly abnormal) and (2) s-factor (structure, categories as p-factor) were compared with the MPS scores. The CSG system was not trained during the study.

Results Considering the p-factor alone, a specificity of >78% and a negative predictive value of mostly >90% for all MPS variables were found. The sensitivities ranged from 17 to 56%, the positive predictive values from 4 to 38%. Combining the p- and the s-factor, significantly higher specificity values of about 90% were reached. The s-factor showed a significant correlation (p=0.006) with the MPS ejection fraction.

Conclusions The CSG system is able to exclude relevant perfusion abnormalities in patients with suspected or known CAD with a specificity and a negative predictive value of about 90% combining the p- and the s-factor. Since it is a learning system there is potential for further improvement before routine use.

Keywords

chronic coronary syndrome, myocardial perfusion SPECT, vectorcardiography, artificial intelligence

• References

• 1 Bundesärztekammer AdwmF, Kassenärztliche Bundesvereinigung. Nationale Versorgungs-Leitlinie Chronische KHK (Langfassung), 6. Auflage. AWMF-Register-Nr.: nvl-004. 2022 www.leitlinien.de/nvl/khk
• 2 Knuuti J, Wijns W, Saraste A. et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41: 407-477
• 3 Braun T, Spiliopoulos S, Veltman C. et al. Detection of myocardial ischemia due to clinically asymptomatic coronary artery stenosis at rest using supervised artificial intelligence-enabled vectorcardiography – A five-fold cross validation of accuracy. J Electrocardiol 2020; 59: 100-105
• 4 Nuklearmedizin DGf. S1-Leitlinie Myokard-Perfusions-SPECT(-CT). AWMF Registernummer 031 – 006. 2023 https://register.awmf.org/de/leitlinien/detail/031–006
• 5 Verberne HJ, Acampa W, Anagnostopoulos C. et al. EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging 2015; 42: 1929-1940
• 6 Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine 2019; 25: 44-56
• 7 McDonagh TA, Metra M, Adamo M. et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal 2021; 42: 3599-3726
• 8 Albus C, Barkhausen J, Fleck E. et al. Diagnostik der chronischen KHK. Dtsch Arztebl Int 2017; 114: 712-719